Back to results
US 7,745,494 B2Granted
Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
AssigneeAlbert Einstein College of Medicine of Yeshiva University
InventorsRoman Perez-Soler, Yi-He Ling
Life of this patent
Estimating the term…
Abstract
The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin.
Claims16
A method for treating a skin rash secondary to an anti-epidermal growth factor receptor (EGFR) therapy in a subject receiving said therapy, the method comprising applying vitamin K3 to the skin in an amount effective to treat the skin rash.
Dependencies are inferred from the claim text.